>

David Brailer - Walgreens Boots Independent Director

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>WA</div>
WBA -- USA Stock  

Earnings Report: 25th of June 2020  

  Director
Dr. David J. Brailer M.D., Ph.D. serves as Independent director of Walgreens boots alliance, inc. He is Chairman of Health Evolution Partners, a private equity firm focused on the healthcare industry, since 2006. He served as National Coordinator for Health Information Technology within the Department of Health and Human Services of the U.S. federal government from May 2004 to April 2006. He was a Senior Fellow at the Health Technology Center from 2002 to 2004. Previously, he served as Chairman and Chief Executive Officer and a director of CareScience, Inc., a provider of care management services and Internetbased healthcare solutions, from 1992 to 2002. Prior to that, he was Adjunct Assistant Professor of Health Care Systems at The Wharton School of Business at the University of Pennsylvania. He serves on the boards of directors of several private companies in the healthcare sector.
Age: 58        
847 315-2500  www.walgreensbootsalliance.com
Brailer served as National Coordinator for Health Information Technology within the Department of Health and Human Services of the U.S. federal government from May 2004 to April 2006. He was a Senior Fellow at the Health Technology Center from 2002 to 2004. Previously, he served as Chairman and Chief Executive Officer and a director of CareScience, Inc., a provider of care management services and Internetbased healthcare solutions, from 1992 to 2002. Prior to that, he was Adjunct Assistant Professor of Health Care Systems at The Wharton School of Business at the University of Pennsylvania.

Management Efficiency

The company has Return on Asset of 0.07 % which means that on every $100 spent on asset it made $0.07 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.14 % implying that it generated $0.14 on every 100 dollars invested.
The company has 17.93 B in debt with debt to equity (D/E) ratio of 74.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. Walgreens Boots Alli has Current Ratio of 0.72 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Daniel BruttoSysco Corporation
2016
Chun LiuVipshop Holdings Limited
2013
Dmitri StocktonTarget Corporation
2018
Susan MulderSally Beauty Holdings Inc Na
2014
Lau PingVipshop Holdings Limited
2017
Steven TownsendSprouts Farmers Market
2013
Joseph FortunatoSprouts Farmers Market
2017
Terry PolistinaSpectrum Brands Holdings
2018
Marshall EisenbergSally Beauty Holdings Inc Na
2006
Monica LozanoTarget Corporation
2016
Nelson PeltzSysco Corporation
2015
Bin WuVipshop Holdings Limited
2008
Bradley HalversonSysco Corporation
2020
David HarrisSpectrum Brands Holdings
2018
Robert EdwardsTarget Corporation
2015
Jonathan GoldenSysco Corporation
1984
John HinshawSysco Corporation
2018
Kelly MooneySally Beauty Holdings Inc Na
2018
Robert KnowlingRite Aid Corporation
2018
Lawrence MolloySprouts Farmers Market
2019
Frank SavageRite Aid Corporation
N/A

Company Summary

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois. Walgreens Boots operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 232000 people.Walgreens Boots Alliance (WBA) is traded on BATS Exchange in USA and employs 232,000 people.

Walgreens Boots Alli Leadership Team

Alexander Gourlay, Executive VP and President of Walgreens CoView
James Skinner, Executive ChairmanView
David Brailer, Independent DirectorView
Leonard Schaeffer, Independent DirectorView
Nancy Schlichting, Independent DirectorView
Dominic Murphy, DirectorView
Jan Reed, Senior Vice President General Counsel, Corporatye SecretaryView
James Kehoe, Global CFO, Executive Vice President - GlobalView
Anthony Roberts, Senior Vice President Global CIOView
Marco Pagni, Executive Vice President Global Chief Legal and Administrative OfficerView
John Lederer, DirectorView
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global BrandsView
Stefano Pessina, Executive Vice Chairman and CEOView
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of BootsView
Gerald Gradwell, IR Contact OfficerView
Heather Dixon, Senior Vice President Chief Accounting Officer, Global ControllerView
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global ControllerView
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources OfficerView
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market AccessView
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International RetailView
Barry Rosenstein, Independent DirectorView
Jose Almeida, DirectorView
Janice Babiak, Independent DirectorView
William Foote, Lead Independent DirectorView
Ginger Graham, Independent DirectorView
George Fairweather, Global CFO and Executive VPView

Stock Performance Indicators

Current Sentiment - WBA

Walgreens Boots Alli Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Walgreens Boots Alliance. What is your outlook on investing in Walgreens Boots Alliance? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currentnly Active

Purchased over 20 shares of
few days ago
Traded for 134.32
Purchased over 70 shares of
few days ago
Traded for 39.23
Purchased over 300 shares of
few days ago
Traded for 8.62
Check out Your Current Watchlist. Please also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page